Subsequent univariate, multivariate Cox and ROC analysis results showed that the expression level of HYAL2 could act as a prognostic factor for glioma, and it was also correlated with a variety of clinical traits in glioma patients, including histology, IDH status, and 1p19q codeletion status. The gene discussed is HYAL2; the disease is central nervous system cancer.